Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer
Clinical trial NCT02630199 · COMPLETED
Trial details
- NCT number
- NCT02630199
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.